The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2022Undiagnosed Parkinson’s in the Emergency Department: An Opportunity for Early Intervention
Study Rationale: Many patients diagnosed with Parkinson’s disease had signs or symptoms of the disease years before an actual diagnosis is made. An astonishingly high percentage of these patients are...
-
Research Grant, 2022Expanding Genetic Analyses in Parkinson’s Disease
Study Rationale: There is a critical need for greater understanding of the genetic component of Parkinson’s disease, both to predict and diagnose disease, but also to inform drug development efforts...
-
Fall 2021 RFP: Outcome Measures, 2022Common Mitochondrial DNA Deletions as a Peripheral Marker of Parkinson’s Disease
Study Rationale: Mitochondria are small capsules inside cells that generate energy. There are lots of mitochondria in brain cells because the brain uses a lot of energy. Researchers have found that...
-
Diversity, Equity and Inclusivity in Parkinson's research, 2022Parkinson’s Disease in Southern Africa
Study Rationale: Most studies on Parkinson’s disease (PD) are focused on patients in Europe and North America. It is crucial to investigate patterns and the causes PD in other parts of the world. It...
-
Fall 2021 RFP: Outcome Measures, 2022LRRK2 Kinase Activity and Global Proteomic Biomarkers in the Gut of Patients with Parkinson’s and/or Inflammatory Bowl Disease
Study Rationale: Accumulative evidence suggests a strong connection between the brain and the gut, with chronic intestinal inflammation being linked to an increased risk of Parkinson’s disease (PD)...
-
2022: Accelerated Therapeutics Program, 2022Preclinical and Early Clinical Development of NPT1220-478 for the Treatment of Parkinson's Disease
Study Rationale: Parkinson’s disease is a progressive neurodegenerative disorder; meaning that from its inception, neurons are continuously dying with resulting worsening of neurologic symptoms. Two...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.